Jun 2, 2026 07:21AM
May 27, 2026 07:29AM
May 21, 2026 05:01PM
May 12, 2026 05:40AM
May 11, 2026 01:04PM
May 11, 2026 07:31AM
May 10, 2026 11:58PM Guggenheim Starts Bicara Therapeutics Inc (BCAX) at Buy
Apr 19, 2026 10:00AM
Mar 31, 2026 06:39AM
Mar 31, 2026 04:21AM
Mar 25, 2026 06:25AM
Feb 23, 2026 04:54AM
Feb 20, 2026 04:37AM
Feb 11, 2026 04:43PM Goldman Sachs Downgrades Bicara Therapeutics Inc (BCAX) to Neutral
Jan 29, 2026 03:09AM
Jan 15, 2026 09:04AM
Jan 14, 2026 06:56AM
Jan 8, 2026 06:08AM
Dec 22, 2025 07:06AM
Dec 21, 2025 08:00PM
Dec 17, 2025 04:04PM Mizuho Starts Bicara Therapeutics Inc (BCAX) at Neutral
Dec 8, 2025 07:33AM
Nov 10, 2025 05:17PM
Oct 21, 2025 07:27AM
Oct 14, 2025 06:39AM
Oct 13, 2025 07:31AM
Oct 3, 2025 04:36PM
Sep 30, 2025 08:42AM TD Cowen: 'Bicara Therapeutics Inc (BCAX) Remains An Attractive Investment'
Sep 9, 2025 07:16AM
Aug 22, 2025 06:52AM
Aug 19, 2025 06:13AM
Jun 11, 2025 04:07PM
Jun 9, 2025 07:27AM
Jun 3, 2025 07:03AM
Jun 2, 2025 07:08AM Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)
Jun 2, 2025 06:50AM
May 23, 2025 07:39AM
May 22, 2025 05:12PM
May 19, 2025 09:18AM
May 16, 2025 06:43AM
May 13, 2025 04:31PM
Apr 23, 2025 10:02AM Bicara Therapeutics (BCAX) present updated data for Ficerafusp alfa in 1L trial
Apr 17, 2025 05:43AM
Apr 7, 2025 06:39AM
Mar 31, 2025 07:44AM
Mar 27, 2025 01:50PM
Mar 17, 2025 07:06AM
Mar 13, 2025 06:46AM
Feb 11, 2025 04:02PM Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01
Jan 27, 2025 09:33AM

416,810 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All